|
|
Volumn 161, Issue 3, 2004, Pages 581-583
|
|
Medication Adherence Studies in Schizophrenia [5] (multiple letters)
a a a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
FLUPHENAZINE;
HALOPERIDOL DECANOATE;
NEUROLEPTIC AGENT;
CLINICAL PRACTICE;
DRUG BLOOD LEVEL;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRUG EFFICACY;
EXTRAPYRAMIDAL SYMPTOM;
HEALTH PROMOTION;
HIGH RISK PATIENT;
HUMAN;
LETTER;
MEDICAL DECISION MAKING;
MENTAL HEALTH CARE;
OUTCOMES RESEARCH;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
PATIENT MONITORING;
PRIORITY JOURNAL;
PSYCHOSOCIAL CARE;
PSYCHOTHERAPY;
RELAPSE;
SCHIZOPHRENIA;
SOCIAL ADAPTATION;
TECHNIQUE;
TREATMENT INDICATION;
ANTIPSYCHOTIC AGENTS;
COMBINED MODALITY THERAPY;
HUMANS;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PATIENT COMPLIANCE;
PSYCHOTHERAPY;
RECURRENCE;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
|
|
EID: 1542373730
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.161.3.581 Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|